News Industry News Boehringer Ingelheim Initiates U.S. Sites in First-Ever Global Phase III Trial of Investigational Antidote in Patients Taking PRADAXA® November 09, 2014
News Daily News Un Estudio Pone de Manifiesto el Riesgo Clínico de la EAC No Obstructiva November 06, 2014
News Daily News Dabigatran acarrea un Mayor Riesgo de Hemorragias Graves y un Menor Riesgo de Hemorragias Intracraneales Todd Neale November 06, 2014